We are thrilled to announce that Novartis are signing up for the CT:IQ Steering Committee. As a key stakeholder in the Australian Clinical Trials sector, they will bring a wealth of experience and a critical viewpoint to the table.
We are thrilled to announce that Novartis are signing up for the CT:IQ Steering Committee. As a key stakeholder in the Australian Clinical Trials sector, they will bring a wealth of experience and a critical viewpoint to the table.